Compare TRN & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRN | OPCH |
|---|---|---|
| Founded | 1933 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Railroads | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | 1994 | 1996 |
| Metric | TRN | OPCH |
|---|---|---|
| Price | $36.92 | $21.66 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $34.00 | ★ $36.57 |
| AVG Volume (30 Days) | 702.1K | ★ 2.3M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | ★ 85.98 | 3.25 |
| EPS | ★ 0.30 | 0.29 |
| Revenue | $2,156,900,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $1.91 | $7.21 |
| Revenue Next Year | $15.61 | $8.55 |
| P/E Ratio | $121.50 | ★ $75.00 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $22.38 | $18.01 |
| 52 Week High | $37.88 | $36.80 |
| Indicator | TRN | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 61.34 | 50.02 |
| Support Level | $29.87 | $20.82 |
| Resistance Level | $37.36 | $22.42 |
| Average True Range (ATR) | 1.20 | 0.61 |
| MACD | 0.15 | 0.04 |
| Stochastic Oscillator | 85.02 | 44.88 |
Trinity Industries Inc sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in two main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.